Top Suppliers:I want be here

95522-45-5

95522-45-5 structure
95522-45-5 structure
  • Name: Colestilan
  • Chemical Name: 2-(chloromethyl)oxirane,2-methyl-1H-imidazole
  • CAS Number: 95522-45-5
  • Molecular Formula: C7H11ClN2O
  • Molecular Weight: 174.62800
  • Catalog: Research Areas Metabolic Disease
  • Create Date: 2018-06-16 00:36:38
  • Modify Date: 2025-08-21 14:11:15
  • Colestilan (MCI-196) is a non-absorbed, non-calcium-based phosphate binder and is also a non-metallic, anion exchange resin. Colestilan is orally active and can be used for hypercholesterolaemia research[1][2].

Name 2-(chloromethyl)oxirane,2-methyl-1H-imidazole
Synonyms Colestilan
Epichlorohydrin-2-methylimidazole copolymer
Colestimide
MCI 196
Cholebine
Description Colestilan (MCI-196) is a non-absorbed, non-calcium-based phosphate binder and is also a non-metallic, anion exchange resin. Colestilan is orally active and can be used for hypercholesterolaemia research[1][2].
Related Catalog
In Vitro Colestilan (MCI-196) decreases cholesterol levels by bile acid adsorption through the gastrointestinal tract[2]. Colestilan (1 g) binds 2.52 mmol of phosphate at 2–4 mM phosphate concentration and pH7.2 in vitro[2].
In Vivo Colestilan (MCI-196) (0.125 or 0.5 g content per 15 g of the feed; p.o.; 14 days) decreases blood phosphate and urinary phosphorus excretion in rats[3]. Colestilan is able to improve hyperphosphataemia in rats with renal failure induced by adenine administration for 4 weeks[1]. Animal Model: 6-week old Wistar male rats[3] Dosage: 0.125 or 0.5 g content per 15 g of the feed Administration: Oral in feed, 14 days Result: Dose dependently decreased blood phosphate and urinary phosphate excretion.
References

[1]. Locatelli F, et al. Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study. Nephrol Dial Transplant. 2010 Feb;25(2):574-81.

[2]. Kurihara S, et al. Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial. Nephrol Dial Transplant. 2005 Feb;20(2):424-30.

[3]. MATSUKA MASAYUKI, et al. Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia. Patent EP0793960.

Molecular Formula C7H11ClN2O
Molecular Weight 174.62800
Exact Mass 174.05600
PSA 41.21000
LogP 1.34210
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.